| Application no. and date | 13811698.3 (espacenet) (Federated) (European Patent Register), 20131203 | | Patent/reg. no. and date | DK/EP 2925350, 20190130 | | Publication date | 20151007 | | Priority no. and date | US 201261732760 P, 20121203, US 201361801187 P, 20130315 | | EP pub. no. and date |
EP 2925350 20151007 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V148121 | | Inventor | ENGELHARDT, John, J., c/o Bristol-Myers Squibb Company
700 Bay Road
Redwood City, CA 94063, US,
KORMAN, Alan, J., c/o Bristol-Myers Squibb Company
700 Bay Road
Redwood City, CA 94063, US,
QUIGLEY, Michael, c/o Bristol-Myers Squibb Company
700 Bay Road
Redwood City, CA 94063, US,
SELBY, Mark, J., c/o Bristol-Myers Squibb Company
700 Bay Road
Redwood City, CA 94063, US,
WANG, Changyu, 32264 Ashley Way
Union City, CA 94587, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ØGNING AF VIRKSOMHEDEN MOD CANCER AF IMMUNOMODULATORISKE FC-
FUSIONSPROTEINER | | Int. application no. | US2013072918 | | Int. publication no. | WO2014089113 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
